Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations
about
Can animal models of disease reliably inform human studies?A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysIntraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primatesRisk of surgical delivery to deep nuclei: a meta-analysisWhy primate models matter.Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.Preclinical assessment of stem cell therapies for neurological diseases.Extending clinical equipoise to phase 1 trials involving patients: unresolved problemsResearch ethics. Beyond access vs. protection in trials of innovative therapies.Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.α-Synuclein and nonhuman primate models of Parkinson's diseaseEstablished patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's diseaseEthical principles for novel therapies in veterinary practice.Tomorrow, interrupted? Risk, ethics, and medical advance in gene transfer.First-in-human HIV-remission studies: reducing and justifying risk.Challenges to Informed Consent in First-In-Human Trials Involving Novel Treatments: A Case Study of Parkinson's Disease.Studying the lay of the land: views and experiences of professionals in the translational pluripotent stem cell field.Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's DiseaseIntracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the BrainEthical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease
P2860
Q21563449-01B02EDA-C11F-4B49-8DD9-4FA2705B408AQ28728201-E3D1A5B8-A052-42FF-8346-15CE4FCEC208Q28732112-A2CAD94C-6BC3-411A-B031-6893AF96C57EQ30371423-E26A736B-7681-40C5-92CD-9EF2D5E97E67Q30417520-743D3847-4C30-4C70-A11A-0214012D9438Q33851241-FA0E5DEB-5F00-42B1-8A1A-171B06E34143Q34786764-FF36E7A2-888F-4A02-9E31-94C266AA1FCAQ35788038-57CD67C5-3423-4DE0-90A6-E00C4F8BA898Q35893072-E9933A67-0B70-4B54-A8BE-1C2DD8C87289Q36014074-E0D1D47D-9F1C-4242-B9C3-A64D52883893Q36157306-085BF1F3-1105-4A1F-81A2-F0FBA1E9B3ECQ36275707-944D0A14-77CB-4BB0-9CD9-840950115405Q38617877-A5D6D93F-7542-4298-AC54-B09FFCC87BD2Q39502650-65A38121-31B7-4D87-A6B9-7D20BC0051F1Q40688627-DF0F8726-02D3-4758-865B-407B5154F724Q45804789-516BB77E-44FC-4B7F-85C1-F097C716C6CCQ47879705-ACAB0A2C-6458-4049-A854-D80EB39C1EDCQ58172885-B88BD3D0-C0FF-4A2F-9801-5BA4E6D090ADQ58255075-F4964245-A7F2-46B4-BBBF-21B71BDD072EQ58281682-013F2CB1-FC74-4F19-855A-971F6562FDD5
P2860
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Launching invasive, first-in-h ...... isease: ethical considerations
@ast
Launching invasive, first-in-h ...... isease: ethical considerations
@en
Launching invasive, first-in-h ...... isease: ethical considerations
@en-gb
Launching invasive, first-in-h ...... isease: ethical considerations
@nl
type
label
Launching invasive, first-in-h ...... isease: ethical considerations
@ast
Launching invasive, first-in-h ...... isease: ethical considerations
@en
Launching invasive, first-in-h ...... isease: ethical considerations
@en-gb
Launching invasive, first-in-h ...... isease: ethical considerations
@nl
prefLabel
Launching invasive, first-in-h ...... isease: ethical considerations
@ast
Launching invasive, first-in-h ...... isease: ethical considerations
@en
Launching invasive, first-in-h ...... isease: ethical considerations
@en-gb
Launching invasive, first-in-h ...... isease: ethical considerations
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Launching invasive, first-in-h ...... isease: ethical considerations
@en
P2093
Bernard Ravina
Frank W Stahnisch
Mark Bernstein
P2860
P304
P356
10.1002/MDS.22712
P407
P577
2009-10-15T00:00:00Z